Centessa Pharmaceuticals plc ADR’s recent filing unveils that its Chief Business Officer Weinhoff Gregory M unloaded Company’s shares for reported $0.51 million on Sep 10 ’24. In the deal valued at $17.00 per share,30,000 shares were sold. As a result of this transaction, Weinhoff Gregory M now holds 223,369 shares worth roughly $3.8 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, SAHA SAURABH sold 175,000 shares, generating $2,891,822 in total proceeds. Upon selling the shares at $16.52, the Chief Executive Officer now owns 776,924 shares.
Before that, SAHA SAURABH bought 175,000 shares. Centessa Pharmaceuticals plc ADR shares valued at $2,891,822 were divested by the Officer at a price of $16.52 per share.
Oppenheimer initiated its Centessa Pharmaceuticals plc ADR [CNTA] rating to an Outperform in a research note published on July 18, 2024; the price target was $14. A number of analysts have revised their coverage, including Jefferies’s analysts, who increased its forecast for the stock in mid November from “a Hold” to “a Buy”. Morgan Stanley also remained covering CNTA and has increased its forecast on October 26, 2023 with a “an Equal-weight” recommendation from previously “an Underweight” rating. Evercore ISI started covering the stock on June 21, 2023. It rated CNTA as “an Outperform”.
Price Performance Review of CNTA
On Friday, Centessa Pharmaceuticals plc ADR [NASDAQ:CNTA] saw its stock jump 12.52% to $16.99. Over the last five days, the stock has gained 18.81%. Centessa Pharmaceuticals plc ADR shares have risen nearly 113.44% since the year began. Nevertheless, the stocks have risen 152.08% over the past one year. While a 52-week high of $17.25 was reached on 09/13/24, a 52-week low of $5.15 was recorded on 01/11/24. SMA at 50 days reached $11.66, while 200 days put it at $9.73.
Levels Of Support And Resistance For CNTA Stock
The 24-hour chart illustrates a support level at 16.00, which if violated will result in even more drops to 15.00. On the upside, there is a resistance level at 17.79. A further resistance level may holdings at 18.58. The Relative Strength Index (RSI) on the 14-day chart is 73.52, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.01, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 12.66%. Stochastics %K at 59.91% indicates the stock is a holding.
How much short interest is there in Centessa Pharmaceuticals plc ADR?
A steep rise in short interest was recorded in Centessa Pharmaceuticals plc ADR stocks on 2024-08-30, growing by 0.59 million shares to a total of 1.97 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-31 was 1.38 million shares. There was a rise of 29.84%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on June 12, 2023 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $9 price target.
